ArticleBioactive materials2024

Use of a pH-responsive imatinib mesylate sustained-release hydrogel for the treatment of tendon adhesion by inhibiting PDGFRβ/CLDN1 pathway.

Sa Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.